NeuroVive Pharmaceutical AB Operating margin
What is the Operating margin of NeuroVive Pharmaceutical AB?
The Operating margin of NeuroVive Pharmaceutical AB is -81,248.88%
What is the definition of Operating margin?
Operating margin is the ratio of operating income divided by net sales and presented in percent.
ttm (trailing twelve months)
Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.
Operating margin of companies in the Miscellaneous sector on LSE compared to NeuroVive Pharmaceutical AB
What does NeuroVive Pharmaceutical AB do?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Companies with operating margin similar to NeuroVive Pharmaceutical AB
- Shyam Telecom has Operating margin of -87,410.21%
- eSense-Lab Ltd has Operating margin of -86,333.34%
- Xantippe Resources has Operating margin of -85,927.01%
- AXIM Biotechnologies has Operating margin of -84,786.21%
- Manhattan has Operating margin of -84,131.37%
- Accelerate Resources has Operating margin of -81,435.33%
- NeuroVive Pharmaceutical AB has Operating margin of -81,248.88%
- Revolution Medicines Inc has Operating margin of -80,961.32%
- Southern Gold has Operating margin of -79,145.54%
- Seneca Biopharma Inc has Operating margin of -78,961.14%
- Eidos Therapeutics Inc has Operating margin of -78,625.20%
- AB Active ETFs Inc has Operating margin of -77,807.79%
- Icon has Operating margin of -77,251.34%